Xconomy

Xconomy

Xconomy is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. We deliver this valuable content through a unique global network of localized blogs, events, conferences, and other initiatives designed to better connect people and ideas. Find out more at Xconomy.com

Xconomy’s Activity

Thu Jul 10

NL

Article

Xconomy published an article 2:00 PM

Jounce Taps Merck Vet to Lead Cancer Drug Push

Read below for more on this story.

Wed Jul 9

NL

Article

Xconomy published an article 9:01 PM

Regeneron, Sanofi Drug Holds Up in Eczema Study

Read below for more on this exciting story.

NL

Article

Xconomy published an article 2:00 PM

Celgene Drug Misses Mark in Spinal Arthritis Study

Read below for more on this story.

Thu Jul 3

NL

Article

Xconomy published an article 9:02 AM

Regado Halts Big Heart Drug Trial, Shares Hammered

Read below for more.

Wed Jul 2

NL

Article

Xconomy published an article 2:01 PM

VenBio Scores Again as Genentech Pays $1.7B+ for Seragon Pharma

VenBio Scores AGain as Genentech Pays $1.7B+ for Seragon Pharma. Check out the story below.

Thu Jun 19

NL

Article

Xconomy published an article 8:30 PM

Amazon’s Fire Phone: One Big Piece of a Real-World Shopping Push

What are the key features of Amazon's new Fire Phone?

Mon Jun 9

NL

Article

Xconomy published an article 1:03 PM

Merck Scoops Up Idenix in $3.85B Buyout

Merck scoops up Idenix in $3.85B buyout.

Wed May 14

NL

Article

Xconomy published an article 12:05 PM

Celldex, Bristol-Myers Cut Deal on Immuno-Oncology Combo Trial

Celldex, Bristol-Myers cut deal on immuno-oncology combo trial.

Thu May 1

NL

Article

Xconomy published an article 9:55 AM

Merrimack Heads to FDA as Pancreatic Cancer Drug Succeeds in Phase 3

Why is Merrimack soaring this morning?

Mon Apr 21

NL

Article

Xconomy published an article 11:53 AM

Sarepta to Resubmit Application for Duchenne Drug, Shares Boom

Sarepta to resubmit application for Duchenne drug, shares boom

Thu Apr 10

NL

Article

Xconomy published an article 9:53 AM

Agios Taps Wall Street Off Early Data, Aims For $75M

Agios taps Wall Street off early data, aims for $75M.

Tue Apr 8

NL

Article

Xconomy published an article 12:54 PM

Alkermes Scores Phase 3 Win for Long-Lasting Schizophrenia Drug

Alkermes scores phase 3 win for long-lasting schizophrenia drug.

Sun Apr 6

NL

Article

Xconomy published an article 8:18 PM

Agios’s Blood Cancer Drug Shines in First Clinical Test

Agios’s blood cancer drug shines in first clinical test.

Tue Apr 1

NL

Article

Xconomy published an article 2:00 PM

Forma Gets $225M More, and a Potential Buyout, From Celgene

Forma gets $225M more, and a potential buyout, from Celgene.

Mon Mar 31

NL

Article

Xconomy published an article 11:14 AM

FDA Lifts Clinical Hold on Curis Cancer Drug, Shares Surge

The FDA lifts its clinical hold on Curis cancer drug and shares surge on the news.

Tue Mar 25

NL

Article

Xconomy published an article 6:30 PM

Gilead Following Multiple Paths Toward HIV “Functional Cure”

Gilead following multiple paths toward HIV “functional cure.”

Mon Mar 24

NL

Article

Xconomy published an article 6:30 PM

AMRI to Acquire API Manufacturer Cedarburg Pharmaceuticals for $41M

AMRI to acquire API manufacturer Cedarburg Pharmaceuticals for $41M.

Tue Mar 18

NL

Article

Xconomy published an article 6:30 PM

Five Prime, Bristol-Myers Squibb Cut $350M Immuno-Oncology Deal

Five Prime, Bristol-Myers Squibb cut $350M immuno-oncology deal.

Thu Mar 13

NL

Article

Xconomy published an article 10:29 AM

Partnership With AnaptysBio Gives Tesaro Entree to Immuno-Oncology

Partnership with AnaptysBio gives Tesaro entree to immuno-oncology.

Wed Mar 5

NL

Article

Xconomy published an article 11:00 AM

Biogen, Eisai Join Up in Alzheimer's Drug Pact

Biogen, Eisai join up in Alzheimer’s drug pact.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 75065
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 0
Total Picks 0
Best Pick ( 0)
Worst Pick ( 0)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to Xconomy’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show Xconomy’s 10 Latest Posts